These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 30089248)

  • 1. RETRACTED: Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway.
    Cao B; Liu C; Yang G
    Biomed Pharmacother; 2018 Nov; 107():185-193. PubMed ID: 30089248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RETRACTED: Physcion 8-O-β-glucopyranoside induced ferroptosis via regulating miR-103a-3p/GLS2 axis in gastric cancer.
    Niu Y; Zhang J; Tong Y; Li J; Liu B
    Life Sci; 2019 Nov; 237():116893. PubMed ID: 31606381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RETRACTED: Alpinumisoflavone causes DNA damage in Colorectal Cancer Cells via blocking DNA repair mediated by RAD51.
    Li D; Li X; Li G; Meng Y; Jin Y; Shang S; Li Y
    Life Sci; 2019 Jan; 216():259-270. PubMed ID: 30448264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RETRACTED: Long non-coding RNA LINC00460 promotes epithelial ovarian cancer progression by regulating microRNA-338-3p.
    Liu X; Wen J; Wang H; Wang Y
    Biomed Pharmacother; 2018 Dec; 108():1022-1028. PubMed ID: 30372802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RETRACTED: Amentoflavone suppresses hepatocellular carcinoma by repressing hexokinase 2 expression through inhibiting JAK2/STAT3 signaling.
    Liu B; Yu S
    Biomed Pharmacother; 2018 Nov; 107():243-253. PubMed ID: 30096628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RETRACTED: Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis.
    Wang Q; Yan Y; Zhang J; Guo P; Xing Y; Wang Y; Qin F; Zeng Q
    Biomed Pharmacother; 2018 Aug; 104():28-35. PubMed ID: 29758413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RETRACTED: Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis.
    Liu X; Li Y; Wen J; Qi T; Wang Y
    Biomed Pharmacother; 2020 May; 125():109882. PubMed ID: 32006899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RETRACTED: Physcion 8-O-β-glucopyranoside suppresses tumor growth of Hepatocellular carcinoma by downregulating PIM1.
    Wang Q; Jiang Y; Guo R; Lv R; Liu T; Wei H; Ming H; Tian X
    Biomed Pharmacother; 2017 Aug; 92():451-458. PubMed ID: 28570979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RETRACTED: Protective autophagy induced by physcion suppresses hepatocellular carcinoma cell metastasis by inactivating the JAK2/STAT3 Axis.
    Pan X; Wang C; Li Y; Zhu L; Zhang T
    Life Sci; 2018 Dec; 214():124-135. PubMed ID: 30389439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RETRACTED: Neferine inhibits proliferation, migration and invasion of U251 glioma cells by down-regulation of miR-10b.
    Liang HX; Sun LB; Liu NJ
    Biomed Pharmacother; 2019 Jan; 109():1032-1040. PubMed ID: 30551353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RETRACTED: lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer.
    Jiang F; Qi W; Wang Y; Wang W; Fan L
    Biomed Pharmacother; 2019 Jun; 114():108814. PubMed ID: 30953817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RETRACTED: Autophagy is a pro-survival mechanism in ovarian cancer against the apoptotic effects of euxanthone.
    Zhu L; Liu X; Li D; Sun S; Wang Y; Sun X
    Biomed Pharmacother; 2018 Jul; 103():708-718. PubMed ID: 29680739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RETRACTED: Long noncoding RNA SNHG16 promotes human retinoblastoma progression via sponging miR-140-5p.
    Xu C; Hu C; Wang Y; Liu S
    Biomed Pharmacother; 2019 Sep; 117():109153. PubMed ID: 31234025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RETRACTED: Baicalein inhibits proliferation and migration of bladder cancer cell line T24 by down-regulation of microRNA-106.
    Jiang L; Song H; Guo H; Wang C; Lu Z
    Biomed Pharmacother; 2018 Nov; 107():1583-1590. PubMed ID: 30257376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RETRACTED: Long noncoding RNA RMRP upregulation aggravates myocardial ischemia-reperfusion injury by sponging miR-206 to target ATG3 expression.
    Kong F; Jin J; Lv X; Han Y; Liang X; Gao Y; Duan X
    Biomed Pharmacother; 2019 Jan; 109():716-725. PubMed ID: 30551524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RETRACTED: Long non-coding RNA NEAT1 plays an important role in sepsis-induced acute kidney injury by targeting miR-204 and modulating the NF-κB pathway.
    Chen Y; Qiu J; Chen B; Lin Y; Chen Y; Xie G; Qiu J; Tong H; Jiang D
    Int Immunopharmacol; 2018 Jun; 59():252-260. PubMed ID: 29669307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETRACTED: Knockdown of long non-coding RNA CCAT1 suppresses proliferation and EMT of human cervical cancer cell lines by down-regulating Runx2.
    Li R; Liu J; Qi J
    Exp Mol Pathol; 2020 Apr; 113():104380. PubMed ID: 31935379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RETRACTED: Physcion induces mitochondria-driven apoptosis in colorectal cancer cells via downregulating EMMPRIN.
    Chen X; Gao H; Han Y; Ye J; Xie J; Wang C
    Eur J Pharmacol; 2015 Oct; 764():124-133. PubMed ID: 26144377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RETRACTED: Astragaloside protects oxygen and glucose deprivation induced injury by regulation of microRNA-21 in retinal ganglion cell line RGC-5.
    Bao H; Sun D; Qi P; Jiang S
    Biomed Pharmacother; 2019 Jan; 109():1826-1833. PubMed ID: 30551437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RETRACTED: Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis.
    Hu C; Liu S; Han M; Wang Y; Xu C
    Biomed Pharmacother; 2018 Nov; 107():547-554. PubMed ID: 30114638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.